Marvell Technology (NASDAQ:MRVL) Stock: Insider Matthew Murphy Sells ...
π Insider Sandeep Bharathi sold 3,685 shares for $865,864.45 to cover tax withholding obligations under a pre-arranged Rule 10b5-1 trading plan.
π MRVL stock declined $13.41 to close at $227.83 with elevated volume of 21.36 million shares on Friday.
π° The company reported Q2 EPS of $0.94, beating estimates by $0.01, and revenue of $2.74 billion, exceeding the $2.72 billion consensus.
π Quarterly revenue increased 36.5% year-over-year while maintaining a net margin of 27.93% and return on equity of 13.57%.
π΅ Marvell announced a quarterly dividend of $0.06 per share, payable on October 29th to shareholders of record on October 9th.
π― Morgan Stanley increased its price target from $268.00 to $300.00 while maintaining an 'equal weight' rating on the stock.
π Oppenheimer reiterated an 'outperform' rating and set a high price target of $425.00 for Marvell Technology shares.
π Goldman Sachs restated a 'neutral' rating with a $270.00 price objective, contrasting with other bullish analyst views.
ποΈ Institutional ownership remains strong at 83.51%, with several asset management firms initiating new positions in Q2 and Q3.
π Marvell has set Q3 2027 guidance between $1.050 and $1.150 EPS, indicating long-term earnings expectations.
- Marvell Technology reported Q2 revenue of $2.74 billion, beating analyst estimates of $2.72 billion and achieving a net margin of 27.93%.
- The company's quarterly revenue grew 36.5% year-over-year, demonstrating strong top-line growth in its semiconductor business.
- Morgan Stanley increased its price target to $300.00, reflecting confidence in the company's future prospects despite the current stock dip.
- Oppenheimer maintained an 'outperform' rating with a high price target of $425.00, signaling strong bullish sentiment from major analysts.
- The consensus average price target stands at $327.36, which is significantly higher than the current trading price of approximately $227.83.
- Marvell achieved a return on equity of 13.57% and maintained a healthy debt-to-equity ratio of 0.27, indicating solid financial health.
- Several institutional investors, including C M Bidwell & Associates Ltd. and Aberdeen Wealth Management LLC, initiated new positions in the stock during Q2.
- Insider Sandeep Bharathi sold 3,685 shares worth $865,864.45, representing a 5.90% decrease in his holdings, which may signal reduced insider confidence.
- The stock price dropped $13.41 to close at $227.83, trading below its 50-day moving average of $241.14 and facing short-term downward pressure.
- Goldman Sachs restated a 'neutral' rating with a $270.00 price objective, which is lower than the bullish targets set by other major analysts like Morgan Stanley.